Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever.
| Autor: | Froeschle JE; Scientific and Medical Affairs, Sanofi Pasteur, Swiftwater, PA 18370, United States. jim.froeschle@sanofipasteur.com, Decker MD |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Vaccine [Vaccine] 2010 Feb 10; Vol. 28 (6), pp. 1451-3. Date of Electronic Publication: 2009 Dec 08. |
| DOI: | 10.1016/j.vaccine.2009.11.051 |
| Abstrakt: | After a single injection of Typhim Vi (typhoid Vi polysaccharide vaccine), serum antibody concentrations were monitored for 3 years in 37 adults who resided where typhoid fever was not endemic. Anti-Vi antibody concentrations declined progressively during the study, to levels that support the current US recommendation for revaccination every 2 years. (Copyright (c) 2009 Elsevier Ltd. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect